EUDA Health Holdings Ltd Financials
EUDA Health Holdings Ltd (EUDA) reported $6.8M in revenue for fiscal year 2025, up 70.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sharper gross economics lifted FY2025 results, but persistent cash burn and thin liquidity show the business still depends on funding.
From the prior year to FY2025, gross margin expansion from19.0% to43.9% changed the earnings shape. Operating margin improved to-36.3% even though SG&A remained above$4.1M , so the recovery came from better cost-of-revenue economics, not leaner overhead.
The losses now look cash-real: operating cash flow of
The balance sheet is short-term constrained: cash was just
Financial Health Signals
EUDA Health Holdings Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
EUDA Health Holdings Ltd scores -42.94, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($43.1M) relative to total liabilities ($6.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
EUDA Health Holdings Ltd passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
EUDA Health Holdings Ltd reported a net loss of $2.8M while operations used $2.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.
EUDA Health Holdings Ltd reported an operating loss of $2.5M against $229K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
EUDA Health Holdings Ltd generated $6.8M in revenue in fiscal year 2025. This represents an increase of 70.0% from the prior year.
EUDA Health Holdings Ltd's EBITDA was -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 86.7% from the prior year.
EUDA Health Holdings Ltd reported -$2.8M in net income in fiscal year 2025. This represents an increase of 81.9% from the prior year.
EUDA Health Holdings Ltd earned -$1.48 per diluted share (EPS) in fiscal year 2025.
Cash & Balance Sheet
EUDA Health Holdings Ltd recorded an outflow of $2.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 17.5% from the prior year.
EUDA Health Holdings Ltd held $345K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
EUDA Health Holdings Ltd's gross margin was 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 24.9 percentage points from the prior year.
EUDA Health Holdings Ltd's operating margin was -36.3% in fiscal year 2025, reflecting core business profitability. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
EUDA Health Holdings Ltd's net profit margin was -40.6% in fiscal year 2025, showing the share of revenue converted to profit. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for fiscal year 2025.
Capital Allocation
EUDA Health Holdings Ltd invested $249 in research and development in fiscal year 2025.
EUDA Health Holdings Ltd invested $77K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.2% from the prior year.
Not reported for fiscal year 2025.
EUDA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Revenue | $6.8M+70.0% | $4.0M+8.2% | $3.7M-1.5% | $3.8M-17.4% | $4.6M |
| Cost of Revenue | $3.8M+17.8% | $3.2M+13.4% | $2.9M-1.0% | $2.9M-12.5% | $3.3M |
| Gross Profit | $3.0M+292.7% | $762K-9.5% | $842K-3.2% | $870K-30.4% | $1.2M |
| R&D Expenses | $249 | N/A | N/A | $17K-86.7% | $129K |
| SG&A Expenses | $4.1M+29.2% | $3.2M-24.8% | $4.3M-26.6% | $5.8M+293.9% | $1.5M |
| Operating Income | -$2.5M+85.7% | -$17.3M-337.6% | -$4.0M+67.6% | -$12.2M-2082.0% | -$560K |
| Interest Expense | $229K+409.3% | $45K+93.3% | $23K | N/A | N/A |
| Income Tax | $42K+1057.6% | -$4K | N/A | -$21K-144.7% | $46K |
| Net Income | -$2.8M+81.9% | -$15.4M-53.0% | -$10.0M+59.7% | -$24.9M-2977.3% | $865K |
| EPS (Diluted) | -$1.48 | -$9.46-7.9% | -$8.77 | -$2.07 | $0.09 |
EUDA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Total Assets | $1.7M+1.1% | $1.7M+29.6% | $1.3M-94.9% | $25.6M+220.4% | $8.0M |
| Current Assets | $1.0M+36.2% | $763K+5.5% | $723K-97.1% | $25.0M+475.0% | $4.4M |
| Cash & Equivalents | $345K+45.3% | $238K+25.7% | $189K+228.5% | $58K-69.7% | $190K |
| Inventory | $3K-97.8% | $129K | N/A | N/A | N/A |
| Accounts Receivable | $243K+66.0% | $146K-38.4% | $237K+23.1% | $193K-89.3% | $1.8M |
| Goodwill | N/A | $0 | $0 | N/A | $993K |
| Total Liabilities | $6.0M+40.1% | $4.3M-51.4% | $8.8M-69.8% | $29.1M+293.8% | $7.4M |
| Current Liabilities | $5.8M+40.9% | $4.1M-52.5% | $8.7M-70.1% | $29.1M+298.0% | $7.3M |
| Total Equity | -$4.3M-66.7% | -$2.6M+66.0% | -$7.5M-113.0% | -$3.5M-775.4% | $521K |
| Retained Earnings | -$52.9M-5.5% | -$50.1M-44.2% | -$34.7M-40.6% | -$24.7M-13799.0% | $180K |
Not reported in any period shown, so not listed: Long-Term Debt.
EUDA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$2.4M-19.3% | -$2.0M+30.3% | -$2.9M-91.1% | -$1.5M-443.9% | $444K |
| Capital Expenditures | $77K-20.2% | $97K | N/A | $18K+1547.3% | $1K |
| Free Cash Flow | -$2.5M-17.5% | -$2.1M | N/A | -$1.5M-448.9% | $443K |
| Investing Cash Flow | -$104K+29.3% | -$148K | N/A | -$268K+24.7% | -$356K |
| Financing Cash Flow | $2.6M+9.7% | $2.3M-1.2% | $2.4M-5.5% | $2.5M+1578.2% | -$168K |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
EUDA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Gross Margin | 43.9%+24.9pp | 19.0%-3.7pp | 22.7%-0.4pp | 23.1%-4.3pp | 27.4% |
| Operating Margin | -36.3% | -432.2% | -106.9% | -324.6% | -12.3% |
| Net Margin | -40.6% | -382.9% | -270.9% | -661.1% | 19.0% |
| Return on Equity | N/A | N/A | N/A | N/A | 165.9% |
| Return on Assets | -161.5%+743.0pp | -904.5%-138.4pp | -766.1%-669.0pp | -97.1%-107.9pp | 10.8% |
| Current Ratio | 0.180.0x | 0.18+0.1x | 0.08-0.8x | 0.86+0.3x | 0.59 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | 14.20 |
| FCF Margin | -36.7%+16.4pp | -53.1% | N/A | -41.0%-50.7pp | 9.7% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$4.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.18), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where EUDA Health Holdings Ltd Ranks
Frequently Asked Questions
What is EUDA Health Holdings Ltd's annual revenue?
EUDA Health Holdings Ltd (EUDA) reported $6.8M in total revenue for fiscal year 2025. This represents a 70.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is EUDA Health Holdings Ltd's revenue growing?
EUDA Health Holdings Ltd (EUDA) revenue grew by 70.0% year-over-year, from $4.0M to $6.8M in fiscal year 2025.
Is EUDA Health Holdings Ltd profitable?
No, EUDA Health Holdings Ltd (EUDA) reported a net income of -$2.8M in fiscal year 2025, with a net profit margin of -40.6%.
What is EUDA Health Holdings Ltd's EBITDA?
EUDA Health Holdings Ltd (EUDA) had EBITDA of -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is EUDA Health Holdings Ltd's gross margin?
EUDA Health Holdings Ltd (EUDA) had a gross margin of 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is EUDA Health Holdings Ltd's operating margin?
EUDA Health Holdings Ltd (EUDA) had an operating margin of -36.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is EUDA Health Holdings Ltd's net profit margin?
EUDA Health Holdings Ltd (EUDA) had a net profit margin of -40.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is EUDA Health Holdings Ltd's free cash flow?
EUDA Health Holdings Ltd (EUDA) recorded an outflow of $2.5M in free cash flow during fiscal year 2025. This represents a -17.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is EUDA Health Holdings Ltd's operating cash flow?
EUDA Health Holdings Ltd (EUDA) recorded an outflow of $2.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are EUDA Health Holdings Ltd's total assets?
EUDA Health Holdings Ltd (EUDA) had $1.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are EUDA Health Holdings Ltd's capital expenditures?
EUDA Health Holdings Ltd (EUDA) invested $77K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does EUDA Health Holdings Ltd spend on research and development?
EUDA Health Holdings Ltd (EUDA) invested $249 in research and development during fiscal year 2025.
What is EUDA Health Holdings Ltd's current ratio?
EUDA Health Holdings Ltd (EUDA) had a current ratio of 0.18 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is EUDA Health Holdings Ltd's return on assets (ROA)?
EUDA Health Holdings Ltd (EUDA) had a return on assets of -161.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does EUDA Health Holdings Ltd's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, EUDA Health Holdings Ltd (EUDA) held $345K in cash, cash equivalents and investments, and reported an operating cash outflow of $2.4M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is EUDA Health Holdings Ltd's debt-to-equity ratio negative or not reported?
EUDA Health Holdings Ltd (EUDA) has negative shareholder equity of -$4.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is EUDA Health Holdings Ltd's Altman Z-Score?
EUDA Health Holdings Ltd (EUDA) has an Altman Z-Score of -42.94, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is EUDA Health Holdings Ltd's Piotroski F-Score?
EUDA Health Holdings Ltd (EUDA) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are EUDA Health Holdings Ltd's earnings high quality?
EUDA Health Holdings Ltd (EUDA) reported a net loss of $2.8M while operations used $2.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can EUDA Health Holdings Ltd cover its interest payments?
EUDA Health Holdings Ltd (EUDA) reported an operating loss of $2.5M against $229K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.